'Stroke drug can help cure cancer'
Scientists identify a substance that can kill cancerous cells without harming healthy ones, a finding they say will pave the way for more effective cancer treatment.
bdnews24.com News Service
bdnews24.com
Published :
09 Apr 2012, 07:09 AM
Updated :
09 Aug 2022, 03:39 PM
Dhaka, Apr 9 (bdnews24.com) – A substance have been identified that scientists say can kill cancerous cells without harming healthy ones, paving the way for more effective cancer treatment.
The findings by researchers at Tel Aviv University and Sheba Medical Center, Tel Hashomer, were published in the current issue of the international peer-reviewed journal Breast Cancer Research.
"We actually found the Achilles heel of the cancer cell," said Prof. Malka Cohen-Armon of Tel Aviv University, who headed the research team.
He said as soon as the cancerous cells can be targeted without killing the healthy ones, medicines can be produced that would cause 'a lot less suffering to the patient'.
"We can even give a much more aggressive treatment without worrying about harming healthy tissues."
The substance identified by the researchers, which delays cell proliferation in healthy and cancerous cells, is a component of a drug developed a decade ago to preserve nerve cells and prevent them from dying after a stroke, an Israeli newspaper reports quoting the researchers.
But while the drug causes the rapid death of cancer cells, healthy cells activate a mechanism that overcomes the delay in proliferation within hours, and those cells continue to proliferate exactly like cells not exposed to the substance, the Haaretz newspaper reports.
Cohen-Armon said the drug's effectiveness in treating cancer cells was discovered accidentally.
She said the scientists involved in the discovery haven't figured out why the drug affects the cells the way it does.
She said the drug was tested on several types of cancer, but so far only the breast cancer tests results have been published.
The experiment has been carried out on female mice, which were injected with human cancerous cells. The substance was gradually released over two weeks. The mice that weren't treated with the substance developed malignant tumors - but in those that got the treatment, the substance either prevented or significantly stalled the development of the cancerous cells, the report says.
The experiments did not find any changes in the behavior of the mice treated with the substance.
The medicine is registered as a patent of an American pharmaceutical company which is one of the obstacles to applying the discovery to all forms of cancer. Tel Aviv University's technology transfer company, Ramot, has secured a usage patent enabling it to develop the drug to treat only breast cancer, the report says.
The future development of the drug depends on the goodwill of the American company, or on another company developing a similar substance.
"We really want to develop this drug, but there are some completely non-scientific obstacles," Cohen-Armon said. "I hope the research doesn't fade away because of that."
bdnews24.com/zk/1245h